Chia Tai Tianqing at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Chia Tai Tianqing brings 4 presentations to ENA 2026 in Barcelona. Its posters present preclinical data on new targeted drugs, including degraders and molecular glues. They cover TQB3306, a menin-MLL inhibitor for acute leukemia, the fourth-generation ALK inhibitor TQB5410, the BCL-XL PROTAC TQB3142 and TQB3125, an oral pan-RAS(ON) molecular glue for KRAS-mutant pancreatic cancer.
| Organization | ENA 2026 Attendance |
|---|---|
Chia Tai Tianqing Lianyungang, China | |
Pharmaceutical company, part of Sino Biopharmaceutical, developing targeted cancer drugs including degraders and molecular glues. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from Chia Tai Tianqing
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction